Nj State Employees Deferred Compensation Plan Ligand Pharmaceuticals Inc Transaction History
Nj State Employees Deferred Compensation Plan
- $761 Million
- Q1 2025
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 5,000 shares of LGND stock, worth $575,050. This represents 0.07% of its overall portfolio holdings.
Number of Shares
5,000
Previous 5,000
-0.0%
Holding current value
$575,050
Previous $535,000
1.87%
% of portfolio
0.07%
Previous 0.07%
Shares
6 transactions
Others Institutions Holding LGND
# of Institutions
280Shares Held
19MCall Options Held
9.5KPut Options Held
8.1K-
Black Rock Inc. New York, NY2.87MShares$330 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$236 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.03MShares$118 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3906KShares$104 Million0.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX745KShares$85.7 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.94B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...